We are proud to announce the first milestone of our journal in 2025: Exploration of Neuroprotective Therapy has successfully passed the rigorous review of the Committee on Publication Ethics (COPE, https://publicationethics.org/), and its application for COPE membership has been approved on February 21, 2025. This milestone serves as a strong endorsement of our unwavering commitment to upholding the highest standards in publication ethics.
This recognition fuels our resolve to maintain academic rigor, foster transparent research dissemination, and contribute meaningfully to the advancement of neuroscience. Together, we will continue shaping a trustworthy academic ecosystem that propels groundbreaking discoveries and scientific progress.
We really appreciate the efforts of our Editors-in-Chief, Board Members, Guest Editors, authors, and reviewers.
The journal details can be found at: https://members.publicationethics.org/members/exploration-neuroprotective-therapy [Update on April 28, 2025]
ENT’s Editorial Board Member is actively promoting the journal’s Scopus inclusion news
Exploration of Neuroprotective Therapy accepted for Scopus
ENT promoted in the International Congress on Neurodegenerative Diseases ICND2024
ENT in the Sino-German Symposium Brain Functions: Neurons, Glia and their Interactions in Health and Disease